Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial,
Introducing Oncotarget.
As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.
Publication Alerts
Subscribe to receive alerts once a paper has been published by Oncotarget.
Shanchun Guo, Changde Zhang, Melyssa Bratton, Madhusoodanan Mottamal, Jiawang Liu, Peng Ma, Shilong Zheng, Qiu Zhong, Lin Yang, Thomas E. Wiese, Yong Wu, Matthew J. Ellis, Margarite Matossian, Matthew E. Burow, Lucio Miele, Rene Houtman, Guangdi Wang
Published Jan 8, 2018 · Vol. 9, No. 6 · pp. 6924-6937
Paul Zolkind, Dariusz Przybylski, Nemanja Marjanovic, Lan Nguyen, Tianxiang Lin, Tanner Johanns, Anton Alexandrov, Liye Zhou, Clint T. Allen, Alexander P. Miceli, Robert D. Schreiber, Maxim Artyomov, Gavin P. Dunn, Ravindra Uppaluri
Published Dec 28, 2017 · Vol. 9, No. 3 · pp. 4109-4119
Viktor Arnhold, Karin Schmelz, Jutta Proba, Annika Winkler, Jasmin Wünschel, Joern Toedling, Hedwig E. Deubzer, Annette Künkele, Angelika Eggert, Johannes H. Schulte, Patrick Hundsdoerfer
Published Dec 18, 2017 · Vol. 9, No. 2 · pp. 2304-2319
